CLINICAL_TRIALS
research
· 2026-03-02
Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 2]
Summary
A Phase 2 clinical trial is evaluating the safety and efficacy of Umbilical Cord Blood Therapy for cancer treatment-induced thrombocytopenia, and is currently r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhejiang Cancer Hospital | Conditions: Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia | Phase 2 | Status: RECRUITING